An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort

Thiopurine S-methyltransferase (TPMT) is an enzyme that converts thiopurine drugs into inactive metabolites. Over 20 variant TPMT-encoding alleles, which cause reduced enzymatic activity, have been discovered so far. Our aim was to investigate the frequencies of variant alleles, i.e. genotypes in in...

Full description

Bibliographic Details
Main Authors: Vladimir Borzan, Marko Brinar, Boris Vucelić, Silvija Čuković-Čavka, Agata Ladić, Nada Božina
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2016-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:http://hrcak.srce.hr/file/237733
id doaj-a6f575435c944af08015782861ea24da
record_format Article
spelling doaj-a6f575435c944af08015782861ea24da2020-11-24T21:19:52ZengSestre Milosrdnice University hospital, Institute of Clinical Medical Research Acta Clinica Croatica0353-94661333-94512016-01-0155.1.1622An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient CohortVladimir Borzan0Marko Brinar1Boris Vucelić2Silvija Čuković-Čavka3Agata Ladić4Nada Božina5Division of Gastroenterology, Osijek University Hospital Center, Osijek, CroatiaDivision of Gastroenterology and Hepatology, Zagreb University Hospital Center, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, CroatiaDivision of Gastroenterology and Hepatology, Zagreb University Hospital Center, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, CroatiaDivision of Gastroenterology and Hepatology, Zagreb University Hospital Center, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, CroatiaDivision of Gastroenterology and Hepatology, Zagreb Univesity Hospital Center, Zagreb, CroatiaClinical Department of Laboratory Diagnosis, Zagreb University Hospital Center, Zagreb, Croatia ; School of Medicine, University of Zagreb, Zagreb, CroatiaThiopurine S-methyltransferase (TPMT) is an enzyme that converts thiopurine drugs into inactive metabolites. Over 20 variant TPMT-encoding alleles, which cause reduced enzymatic activity, have been discovered so far. Our aim was to investigate the frequencies of variant alleles, i.e. genotypes in inflammatory bowel disease (IBD) patients and healthy individuals and to compare these frequencies with selected world populations. The most common variant alleles TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C were analyzed with polymerase chain reactionbased assays and allele-specific polymerase chain reaction-based assays in 685 participants including 459 IBD patients and 226 healthy volunteers. Study results revealed 434/459 (94.55%) IBD patients and 213/226 (94.25%) healthy subjects to be homozygous for the wild-type allele (TPMT*1/*1). TPMT*1/*2 and TPMT *1/*3C genotypes were found in 4/459 (0.87%) and 7/459 (1.53%) IBD patients, respectively; in healthy volunteers they were not found. TPMT*1/*3A genotype was found in 14/459 (3.05%) IBD patients and 13/226 (5.75%) healthy subjects. Variant genotypes were statistically significantly more common in Crohn’s disease subgroup than in ulcerative colitis subgroup. The prevalence of variant genotypes was 23/338 (6.80%) in Crohn’s disease subgroup as compared with 2/121 (1.65%) in ulcerative colitis subgroup (χ2=4.59; p=0.032). In conclusion, the most frequently occurring nonfunctional TPMT allele in Croatian population is TPMT*3A. The overall frequency of mutant alleles in our population is statistically nonsignificantly lower when compared with other populations of Caucasian origin. The Crohn’s disease group had more mutant alleles than the ulcerative colitis group.http://hrcak.srce.hr/file/237733Crohn’s disease – geneticsColitis, ulcerative – geneticsThiopurine-S-methyltransferase deficiencyPolymorphism, genetic
collection DOAJ
language English
format Article
sources DOAJ
author Vladimir Borzan
Marko Brinar
Boris Vucelić
Silvija Čuković-Čavka
Agata Ladić
Nada Božina
spellingShingle Vladimir Borzan
Marko Brinar
Boris Vucelić
Silvija Čuković-Čavka
Agata Ladić
Nada Božina
An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
Acta Clinica Croatica
Crohn’s disease – genetics
Colitis, ulcerative – genetics
Thiopurine-S-methyltransferase deficiency
Polymorphism, genetic
author_facet Vladimir Borzan
Marko Brinar
Boris Vucelić
Silvija Čuković-Čavka
Agata Ladić
Nada Božina
author_sort Vladimir Borzan
title An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
title_short An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
title_full An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
title_fullStr An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
title_full_unstemmed An Epidemiological Study of Thiopurinemethyltransferase Variants in a Croatian Inflammatory Bowel Disease Patient Cohort
title_sort epidemiological study of thiopurinemethyltransferase variants in a croatian inflammatory bowel disease patient cohort
publisher Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
series Acta Clinica Croatica
issn 0353-9466
1333-9451
publishDate 2016-01-01
description Thiopurine S-methyltransferase (TPMT) is an enzyme that converts thiopurine drugs into inactive metabolites. Over 20 variant TPMT-encoding alleles, which cause reduced enzymatic activity, have been discovered so far. Our aim was to investigate the frequencies of variant alleles, i.e. genotypes in inflammatory bowel disease (IBD) patients and healthy individuals and to compare these frequencies with selected world populations. The most common variant alleles TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C were analyzed with polymerase chain reactionbased assays and allele-specific polymerase chain reaction-based assays in 685 participants including 459 IBD patients and 226 healthy volunteers. Study results revealed 434/459 (94.55%) IBD patients and 213/226 (94.25%) healthy subjects to be homozygous for the wild-type allele (TPMT*1/*1). TPMT*1/*2 and TPMT *1/*3C genotypes were found in 4/459 (0.87%) and 7/459 (1.53%) IBD patients, respectively; in healthy volunteers they were not found. TPMT*1/*3A genotype was found in 14/459 (3.05%) IBD patients and 13/226 (5.75%) healthy subjects. Variant genotypes were statistically significantly more common in Crohn’s disease subgroup than in ulcerative colitis subgroup. The prevalence of variant genotypes was 23/338 (6.80%) in Crohn’s disease subgroup as compared with 2/121 (1.65%) in ulcerative colitis subgroup (χ2=4.59; p=0.032). In conclusion, the most frequently occurring nonfunctional TPMT allele in Croatian population is TPMT*3A. The overall frequency of mutant alleles in our population is statistically nonsignificantly lower when compared with other populations of Caucasian origin. The Crohn’s disease group had more mutant alleles than the ulcerative colitis group.
topic Crohn’s disease – genetics
Colitis, ulcerative – genetics
Thiopurine-S-methyltransferase deficiency
Polymorphism, genetic
url http://hrcak.srce.hr/file/237733
work_keys_str_mv AT vladimirborzan anepidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT markobrinar anepidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT borisvucelic anepidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT silvijacukoviccavka anepidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT agataladic anepidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT nadabozina anepidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT vladimirborzan epidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT markobrinar epidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT borisvucelic epidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT silvijacukoviccavka epidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT agataladic epidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
AT nadabozina epidemiologicalstudyofthiopurinemethyltransferasevariantsinacroatianinflammatoryboweldiseasepatientcohort
_version_ 1726004825592692736